Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-029530
Filing Date
2025-04-08
Accepted
2025-04-07 18:30:37
Documents
15
Period of Report
2025-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0237445-8ka1_pmgc.htm   iXBRL 8-K/A 42490
2 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EXEC ea023744501ex10-1_pmgc.htm EX-10.1 17192
3 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EMPL ea023744501ex10-2_pmgc.htm EX-10.2 20255
  Complete submission text file 0001213900-25-029530.txt   274970

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE elab-20250403.xsd EX-101.SCH 3026
5 XBRL LABEL FILE elab-20250403_lab.xml EX-101.LAB 34915
6 XBRL PRESENTATION FILE elab-20250403_pre.xml EX-101.PRE 22796
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0237445-8ka1_pmgc_htm.xml XML 4776
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41875 | Film No.: 25819272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)